FDA Clears OTC CGM for Children: What Families Should Know
FDA cleared Dexcom Stelo as the first over-the-counter CGM for children age 2 and older...
FDA Authorizes Libre Duo: Continuous Glucose and Ketone Monitoring Explained
The FDA has authorized Libre Duo 10 Day for people aged 2 and older with...
FDA Approves an Adjustable Heart Valve for Children: What Families Should Know
The FDA has approved an adjustable pulmonary heart valve for some children. We explain the...
Fatty Liver Disease and Diabetes: Heart Risk to Watch
Plain-language guide to fatty liver disease, diabetes, and cardiovascular risk, with screening questions, safety notes...
Family-Focused Support for Young People With Type 1 Diabetes: What a New Meta-Analysis Found
A meta-analysis of 62 randomized trials found modest HbA1c benefits from behavioral support, with stronger...
Exercise as Part of Heart Care: What the New ACC Statement Means
New ACC advice puts achievable, personalised activity at the centre of heart care. Understand the...
Evolocumab and Cardiovascular Risk in High-Risk Diabetes: What VESALIUS-CV Found
A prespecified VESALIUS-CV analysis found fewer major cardiovascular events with evolocumab in selected adults with...
Early Weight Loss After Type 2 Diabetes Diagnosis: What a Large UK Study Found
A large UK cohort linked 15% early weight loss after type 2 diabetes diagnosis with...
Early Type 1 Diabetes Screening in Children: What Families Should Know
Plain-language guide to early type 1 diabetes screening in children, autoantibodies, risk, follow-up, teplizumab context...